Tagcloud

ACE inhibitor, acetylcholinesterase inhibitor, aciclovir, acne, acute coronary syndrome, acute lymphoblastic leukaemia, ADHD, advanced prostate cancer, advanced renal cell carcinoma, advanced soft tissue sarcoma, adverse reaction, agomelatine, agoraphobia, alendronic acid, alfuzosin, algorithm, aliskiren, allergic rhinitis, allopurinol, alpha1-proteinase inhibitor, Alzheimer's, amantadine hydrochloride, ambrisentan, aminosalicylate, amlodipine, amoxicillin, anaemia, angina pectoris, anidulafungin, ankylosing spondylitis, anti-doping, anti-heparin, anti-human thymocyte immunoglobulin, antibacterial, antibiotic, anticoagulant, antidepressant, antineoplastic, antipsychotic, antiretroviral, antiretroviral therapy, anxiety, aromatase inhibitor, asthma, atazanavir, azacitidine, bacterial infections, BCG Vaccine, beclometasone, behaviour disorders, betamethasone, bevacizumab, bicalutamide, bipolar disorder, bisoprolol fumarate, bisphosphonates, black patients, bladder cancer, bowel cleansing, BPH, breakthrough pain, breast cancer, brinzolamide, bronchospasm, budesonide, bulimia nervosa, calcipotriol, calcium, candesartan, Candida albicans, candidiasis, carbetocin, carbidopa, cardiac insufficiency, cardiovascular disease, cefaclor, ceftriaxone, cefuroxime, cephalosporin, cetirizine, CHF, cholecalciferol, chronic constipation, chronic heart failure, Chronic Kidney Disease, chronic myeloid leukaemia, chronic myelomonocytic leukaemia, chronic pain, chronic pulmonary infection, ciprofloxacin, citalopram hydrobromide, clarithromycin, clavulanic acid, clopidogrel, clotrimazole, clozapine, colorectal cancer, contraception, COPD, coronary artery disease, Crohn’s Disease, cystic fibrosis, dabigatran etexilate, daptomycin, darunavir, dasatinib, degarelix, dementia, depression, dermatophytes, dermatophytose, desogestrel, diabetes, diclofenac, dienogest, diphteria, discontinuations, domperidone, donepezil, doxazosin, doxycycline, drospirenone, duodenal ulcer, dyslipidaemia, eczema, eletriptan, emetogenic cancer chemotherapy, enalapril, endocarditis, entacapone, epigastric bloating, epilepsy, epirubicin, epoetin, ErbB2 (HR2) receptors, erythropoiesis-stimulating agents, esomeprazole, estradiol, ethinylestradiol, etravirine, everolimus, exemestane, faecal impaction, famciclovir, fentanyl, fesoterodine, fever, filgrastim, finasteride, fluconazole, fluoxetine, flurbiprofen, fluvastatin, folate, folic acid, follicular development stimulation, follicular lymphoma, follitropin alpha, fosprepitant, fungal infections, gabapentin, gastric cancer, gastric ulcer, gastroduodenal ulcer, gemcitabine, gestodene, gliclazide, glucosamine sulphate, gonorrhoea, GORD, growth failure, H1N1, hayfever, heart failure, heart rate, Helicobacter pylori, hepatic failure, hepatitis, hepatocellular carcinoma, herpes, hip or knee replacement surgery, hip osteoarthritis, HIV, hyaluronic acid, hydrochlorothiazide, Hylan G-F 20, hypercholesterolaemia, hyperlipidaemia, hyperphosphataemia, hypertension, hyperuricaemia, hypoactive sexual desire disorder, ibritumomab, ibuprofen, IGF-1 deficiency, IMB, immunosuppression, indacaterol, indapamide, infections, inflammation, influenza, insomnia, interferon beta-1a, iobetasol, IOP, ipatropium bromide, irinotecan, Irish Sports Council, ischaemic stroke, isotretinoin, ivabradine, Kaposi's sarcoma, kidney cancer, kidney disease, knee osteoarthritis, lacosamide, lamotrigine, lansoprazole, lapatinib, laropiprant, lenalidomide, lercanidipine, leuprorelin acetate, levodopa, levonorgestrel, liraglutide, lisinopril, losartan, lutropin alpha, Lyme disease, macrogol, magnesium, mania, maraviroc, mecasermin, melatonergic, melatonin, meloxicam, memantine, mesalazine, metastatic colorectal carcinoma, metformin, methadone, methylnaltrexone bromide, methylphenidate hydrochloride, mexiletine hydrochloride, micafungin, migraine, mirtazapine, mixed dyslipidaemia, moxifloxacin, multiple myeloma, multiple sclerosis, muscular disorders, myelodysplastic syndromes, myocardial infarction, naloxone, naratriptan, nasal congestion, nausea, nebivolol, nephropathy, neural tube defects, neutropenia, NICE guidelines, nicotine, nicotinic acid, nilotinib, NSCLC, nutrition, OCD, ocular hypertension, olanzapine, olmesartan, omeprazole, ondensetron, open angle glaucoma, opioid addiction, opioid analgesic, opioid-induced constipation, oseltamivir, osteoarthritis, osteonecrosis of the jaw, osteoporosis, otitis, ovarian cancer, overactive bladder syndrome, oxycodone, paclitaxel, pain, pancreatic cancer, pancreatic exocrine insufficiency, pancreatin, panic disorder, panitumumab, pantoprazole, paracetamol, Parkinson’s, partial-onset seizures, patch, pemetrexed, peptic ulcer, perindopril, peripheral arterial disease, peripheral neuropathic pain, pertussis, piperacillin, Pityriasis versicolor, poliomyelitis, post transplantation hyperlipidaemia, post-operative pain, post-traumatic stress disorder, PPIs, pramipexole, pravastatin, pregnancy, pricing policy, primary hypercholesterolaemia, probiotics, prostate cancer, protamine sulphate, Pseudomonas aeruginosa, psoriasis, psychotic disorders, pulmonary arterial hypertension, pulmonary embolism, quetiapine, raltegravir, ramipril, ranolazine, rasagiline, recombinant IGF-1, reflux oesophagitis, renal disease, renin inhibitor, Restless Legs Syndrome, rheumatoid arthritis, ribavirin, ringworm, risedronate sodium, risperidone, rivaroxaban, rivastigmine, romiplostim, ropinirole, rosacea, RTI, S. aureus, salbutamol, sarcoma, saxagliptin, schizophrenia, SCLC, sertraline, sevelamer carbonate, severe pain, simvastatin, sitagliptin, smoking cessation, sodium alginate, solide organ transplantation, sorafenib, sore throat, spasticity, spinal cord injury, sport, sprain, statins, stroke, strontium ranelate, suicide, systemic embolisation, telmisartan, temsirolimus, terbinafine, testosterone, tetanus, thalidomide, thrombocytopenic purpura, thrush, tibolone, timolol, tinea, tiotropium, tipranavir, tizanidine, tobramycin, tocilizumab, topotecan, trabectedin, tramadol, Trichophyton, trimethoprim, trospium chloride, ustekinumab, UTI, vaccine, valaciclovir, valproate, valsartan, varenicline, venlafaxine, venous thromboembolism, venous thrombosis, vildagliptin, vinorelbine, vitamin D, vomiting, WADA, warfarin, wound, zanamivir, zoledronic acid, Zollinger-Ellison syndrome

MIMS Ireland: October 2009

Use of Antiviral Medicines for Pandemic Influenza

01 October 2009 | Irish Medicines Board

IMB Update on Use of Antiviral Medicines for Pandemic (H1N1) 2009 Influenza (1). Antiviral medicines are available for the clinical management of pandemic (H1N1) 2009 influenza. Among the antiviral medicines that are authorised in the EU for use in an... Read more

First melatonergic antidepressant Valdoxan showed to have long term efficacy in preventing relapse

01 October 2009 | New Clinical Evidence

Servier wish to announce that the melatonergic agonist Valdoxan (agomelatine) has been approved for the treatment of major depressive episodes.... Read more

Procorolan reduces MI in angina patients

01 October 2009 | New Clinical Evidence

The results of a newly published sub-study of the BEAUTIFUL trial* in patients with limiting angina were announced recently at the ESC in Barcelona, Spain.... Read more

Abstral

01 October 2009 | New Products

Company: Fannin Pharmaceuticals. Legal category: Controlled Drug. GMS. Sport Prohibited. Active ingredient: Fentanyl (as citrate) 50μg, 100μg, 200μg, 300μg, 400μg, 600μg, 800μg. Description: White sublingual tablets. Pentagon, round, oval, triangle, diamond, D and capsule shaped, respectively. Presentation: 10-pack for all... Read more

Aveeno Dermexa Body Wash

01 October 2009 | New Products

Company: Johnson & Johnson (Ireland) Ltd. Legal category: OTC. Active ingredient: Colloidal oatmeal, glycerin, ceramides, dexpenthenol. Extra mild liquid; fragrance free, dye free, colorant free, preservative free. Presentation: 250ml, €8.99. Indications: Gently cleanses and moisturises extra dry and Itchy skin... Read more

Aveeno Dermexa Moisturising Cream

01 October 2009 | New Products

Company: Johnson & Johnson (Ireland) Ltd. Legal category: OTC. Active ingredient: Triple oat technology: Colloidal oatmeal, oat extract (avenanthramides), oat oil, panthenol glycerin, ceramides petrolatum. Presentation: 200ml, €11.95. Indications: Extra dry and itchy skin conditions, including skin prone to eczema.... Read more

Baby D

01 October 2009 | New Products

Company: KoRa Healthcare. Legal category: OTC. Active ingredient: Vitamin D 5μg (200 IU) per 0.2ml dose. Description: Amber bottle with 2 oral syringes. Presentation: 15ml, €5.30. Indication: For the dietary management of vitamin D deficiency in infants between the ages... Read more

Clodel

01 October 2009 | New Products

Company: Rowex Ltd. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Clopidogrel (as HCl) 75mg. Description: Pink, film-coated, round shaped tablets. Presentation: 28, €36.43. Indications: Prevention of atherothrombotic events in adults suffering from myocardial infarction (from a few days until... Read more

Istolde

01 October 2009 | New Products

Company: Actavis Ireland Ltd. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Amlodipine 5mg, 10mg. Description: White, uncoated, round, flat, tablet with score on one side and embossed with AB5 or AB10 on the other side. Presentation: 5mg-28; 10mg-28. Prices... Read more

Konverge

01 October 2009 | New Products

Company: A. Menarini Pharmaceuticals Ireland Ltd / Daiichi Sankyo Ltd. Legal category: Prescription. GMS. Sport permitted. Active ingredients: Olmesartan medoxomil / amlodipine (as besilate), 20mg/5mg, 40mg/5mg, 40mg/10mg. Description: Round, film-coated tablets. 20mg/5mg: White, debossed with C73 on one side. 40mg/5mg:... Read more

Lamotrigine Ranbaxy

01 October 2009 | New Products

Company: Ranbaxy UK. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Lamotrigine 25mg, 50mg, 100mg, 200mg. Description: White to off-white round tablets, debossed with, respectively, L12, L13, L14 or L15 on one side. Presentation: 25mg-56, €13.44; 50mg-56, €21.10 ; 100mg-56,... Read more

Luvinsta

01 October 2009 | New Products

Company: Actavis Ireland Ltd. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Fluvastatin (as Na+) 20mg, 40mg. Description: 20mg: Orange/ivory opaque hard capsule marked with 20 and FST. 40mg: Orange/yellow opaque hard capsule marked with 40 and FST. Presentation: 20mg-28,... Read more

Qlaira

01 October 2009 | New Products

Company: Bayer Schering Pharma. Legal category: Prescription. GMS. Sport Permitted. Active ingredients: Estradiol valerate 3mg (2 dark yellow tablets marked DD), estradiol valerate 2mg and dienogest 2mg (5 medium red tablets marked DJ), estradiol valerate 2mg and dienogest 3mg (17... Read more

Valdoxan

01 October 2009 | New Products

Company: Servier Laboratories (Ireland) Ltd. Legal category: Prescription. Sport Permitted. Active ingredient: Agomelatine 25mg. Description: Orange-yellow, oblong, film-coated tablet marked with company logo. Presentation: Ex-factory price: €39.20. Indication: Treatment of major depressive episodes.... Read more

Rasilez HCT

01 October 2009 | New Presentations

Prescription. GMS. Sport prohibited. Novartis Ireland Ltd. are delighted to announce the introduction of Rasilez HCT, a single pill combination of Rasilez (aliskiren) and hydrochlorothiazide. Rasilez HCT is indicated in the treatment of essential hypertension. The doses available are 150mg/12.5mg,... Read more

Stalevo 75mg and 125mg

01 October 2009 | New Presentations

Prescription. GMS. Sport permitted. An EU-wide marketing authorisation has been granted by the EMEA for two new strengths of Stalevo, the levodopa treatment developed by Orion Pharma for Parkinson’s disease (PD). Stalevo combines levodopa, carbidopa and entacapone in one tablet.... Read more

Zirtek Plus Decongestant

01 October 2009 | New Presentations

Company: UCB (Pharma) Ireland Ltd. Legal category: OTC. Sport permitted. Active ingredients: Cetirizine HCl (immediate release)/ pseudoephedrine HCl (prolonged release), 5mg/120mg. Description: White to off white prolonged release tablets. Presentation: 10, €7.31. Indication: Treatment of symptoms (e.g. nasal congestion, sneezing,... Read more

Konakion Discontinued

01 October 2009 | Discontinued Products

As part of a regular review of products in its pharmaceutical portfolio, Roche Products (Ireland) Ltd wishes to inform you of the discontinuation of one of its products, Konakion 10mg tablets. Marketing of the Konakion 10mg tablets presentation will cease... Read more